Here we go again.

Courtesy of Axios

To the alarm of some government health officials, President Trump has expressed enthusiasm for the Food and Drug Administration to permit an extract from the oleander plant to be marketed as a dietary supplement or, alternatively, approved as a drug to cure COVID-19, despite lack of proof that it works.

The experimental botanical extract, oleandrin, was promoted to Trump during an Oval Office meeting in July. It’s embraced by Housing and Urban Development Secretary Ben Carson and MyPillow founder and CEO Mike Lindell, a big Trump backer, who recently took a financial stake in the company that develops the product.

Lindell told Axios that in the meeting, Trump “basically said: …’The FDA should be approving it.'”

The White House did not respond to requests for comment.

A senior administration official familiar with the internal conversations told Axios, “The involvement of the Secretary of HUD and MyPillow.com in pushing a dubious product at the highest levels should give Americans no comfort at night about their health and safety during a raging pandemic.”

It’s part of a pattern in which entrepreneurs, often without rigorous vetting, push unproven products to Trump — knowing their sales pitches might catch his eye. Trump will then urge FDA Commissioner Stephen Hahn to “look at” or speed up approval.

I would not take any advice from a former junkie who hawks pillows and a guy who always looks like he is barely conscious about ANYTHING, especially a cure for a disease that continues to baffle scientists around the world

The fact that Trump is so incredibly gullible does not exactly give me confidence in his ability to deal with foreign leaders hostile to the interests of the United States. 

For all, we know he might be convinced to sell Alaska back to Russia for a handful of magic beans.